These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 34431361)

  • 1. Racial Disparities in Modifiable Risk Factors and Statin Usage in Black Patients With Familial Hypercholesterolemia.
    Agarwala A; Bekele N; Deych E; Rich MW; Hussain A; Jones LK; Sturm AC; Aspry K; Nowak E; Ahmad Z; Ballantyne CM; Goldberg AC
    J Am Heart Assoc; 2021 Sep; 10(17):e020890. PubMed ID: 34431361
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ethnic differences in guideline-indicated statin initiation for people with type 2 diabetes in UK primary care, 2006-2019: A cohort study.
    Eastwood SV; Mathur R; Sattar N; Smeeth L; Bhaskaran K; Chaturvedi N
    PLoS Med; 2021 Jun; 18(6):e1003672. PubMed ID: 34185782
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Health disparities among adult patients with a phenotypic diagnosis of familial hypercholesterolemia in the CASCADE-FH™ patient registry.
    Amrock SM; Duell PB; Knickelbine T; Martin SS; O'Brien EC; Watson KE; Mitri J; Kindt I; Shrader P; Baum SJ; Hemphill LC; Ahmed CD; Andersen RL; Kullo IJ; McCann D; Larry JA; Murray MF; Fishberg R; Guyton JR; Wilemon K; Roe MT; Rader DJ; Ballantyne CM; Underberg JA; Thompson P; Duffy D; Linton MF; Shapiro MD; Moriarty PM; Knowles JW; Ahmad ZS
    Atherosclerosis; 2017 Dec; 267():19-26. PubMed ID: 29080546
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Subclinical coronary atherosclerosis and cardiovascular risk stratification in heterozygous familial hypercholesterolemia patients undergoing statin treatment.
    Miname MH; Bittencourt MS; Nasir K; Santos RD
    Curr Opin Lipidol; 2019 Apr; 30(2):82-87. PubMed ID: 30649025
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Longitudinal treatment patterns among US patients with atherosclerotic cardiovascular disease or familial hypercholesterolemia initiating lipid-lowering pharmacotherapy.
    Burke JP; Simpson RJ; Paoli CJ; McPheeters JT; Gandra SR
    J Clin Lipidol; 2016; 10(6):1470-1480.e3. PubMed ID: 27919365
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and Safety of Alirocumab in High-Risk Patients With Clinical Atherosclerotic Cardiovascular Disease and/or Heterozygous Familial Hypercholesterolemia (from 5 Placebo-Controlled ODYSSEY Trials).
    McCullough PA; Ballantyne CM; Sanganalmath SK; Langslet G; Baum SJ; Shah PK; Koren A; Mandel J; Davidson MH
    Am J Cardiol; 2018 Apr; 121(8):940-948. PubMed ID: 29472008
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Familial Hypercholesterolemia-Risk-Score: A New Score Predicting Cardiovascular Events and Cardiovascular Mortality in Familial Hypercholesterolemia.
    Paquette M; Bernard S; Cariou B; Hegele RA; Genest J; Trinder M; Brunham LR; Béliard S; Baass A
    Arterioscler Thromb Vasc Biol; 2021 Oct; 41(10):2632-2640. PubMed ID: 34433300
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Statins for children with familial hypercholesterolemia.
    Vuorio A; Kuoppala J; Kovanen PT; Humphries SE; Tonstad S; Wiegman A; Drogari E; Ramaswami U
    Cochrane Database Syst Rev; 2019 Nov; 2019(11):. PubMed ID: 31696945
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of Race on Statin Prescribing for Primary Prevention With High Atherosclerotic Cardiovascular Disease Risk in a Large Healthcare System.
    Dorsch MP; Lester CA; Ding Y; Joseph M; Brook RD
    J Am Heart Assoc; 2019 Nov; 8(22):e014709. PubMed ID: 31707943
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effectiveness and Safety of Lipid-Lowering Drug Treatments in Japanese Patients with Familial Hypercholesterolemia: Familial Hypercholesterolemia Expert Forum (FAME) Study.
    Yamashita S; Masuda D; Harada-Shiba M; Arai H; Bujo H; Ishibashi S; Daida H; Koga N; Oikawa S
    J Atheroscler Thromb; 2022 May; 29(5):608-638. PubMed ID: 33980760
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of Statin Use for Primary Prevention of Atherosclerotic Cardiovascular Disease by Race, Ethnicity, and 10-Year Disease Risk in the US: National Health and Nutrition Examination Surveys, 2013 to March 2020.
    Jacobs JA; Addo DK; Zheutlin AR; Derington CG; Essien UR; Navar AM; Hernandez I; Lloyd-Jones DM; King JB; Rao S; Herrick JS; Bress AP; Pandey A
    JAMA Cardiol; 2023 May; 8(5):443-452. PubMed ID: 36947031
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Statins for children with familial hypercholesterolemia.
    Vuorio A; Kuoppala J; Kovanen PT; Humphries SE; Tonstad S; Wiegman A; Drogari E; Ramaswami U
    Cochrane Database Syst Rev; 2017 Jul; 7(7):CD006401. PubMed ID: 28685504
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical determinants and treatment gaps in familial hypercholesterolemia: Data from a multi-ethnic regional health service.
    Zafrir B; Jubran A; Lavie G; Halon DA; Flugelman MY; Shapira C
    Eur J Prev Cardiol; 2017 May; 24(8):867-875. PubMed ID: 28186442
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment Gaps in Adults With Heterozygous Familial Hypercholesterolemia in the United States: Data From the CASCADE-FH Registry.
    deGoma EM; Ahmad ZS; O'Brien EC; Kindt I; Shrader P; Newman CB; Pokharel Y; Baum SJ; Hemphill LC; Hudgins LC; Ahmed CD; Gidding SS; Duffy D; Neal W; Wilemon K; Roe MT; Rader DJ; Ballantyne CM; Linton MF; Duell PB; Shapiro MD; Moriarty PM; Knowles JW
    Circ Cardiovasc Genet; 2016 Jun; 9(3):240-9. PubMed ID: 27013694
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sex-related differences in premature cardiovascular disease in familial hypercholesterolemia.
    Agarwala A; Deych E; Jones LK; Sturm AC; Aspry K; Ahmad Z; Ballantyne CM; Goldberg AC
    J Clin Lipidol; 2023; 17(1):150-156. PubMed ID: 36470719
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Statins for children with familial hypercholesterolemia.
    Vuorio A; Kuoppala J; Kovanen PT; Humphries SE; Tonstad S; Wiegman A; Drogari E
    Cochrane Database Syst Rev; 2014 Jul; (7):CD006401. PubMed ID: 25054950
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Statins for children with familial hypercholesterolemia.
    Vuorio A; Kuoppala J; Kovanen PT; Humphries SE; Strandberg T; Tonstad S; Gylling H
    Cochrane Database Syst Rev; 2010 Jul; (7):CD006401. PubMed ID: 20614444
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long term follow-up of genetically confirmed patients with familial hypercholesterolemia treated with first and second-generation statins and then with PCSK9 monoclonal antibodies.
    Pasta A; Cremonini AL; Formisano E; Fresa R; Bertolini S; Pisciotta L
    Atherosclerosis; 2020 Sep; 308():6-14. PubMed ID: 32771803
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence and Predictors of Cholesterol Screening, Awareness, and Statin Treatment Among US Adults With Familial Hypercholesterolemia or Other Forms of Severe Dyslipidemia (1999-2014).
    Bucholz EM; Rodday AM; Kolor K; Khoury MJ; de Ferranti SD
    Circulation; 2018 May; 137(21):2218-2230. PubMed ID: 29581125
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pooled Patient-Level Analysis of Inclisiran Trials in Patients With Familial Hypercholesterolemia or Atherosclerosis.
    Wright RS; Ray KK; Raal FJ; Kallend DG; Jaros M; Koenig W; Leiter LA; Landmesser U; Schwartz GG; Friedman A; Wijngaard PLJ; Garcia Conde L; Kastelein JJP;
    J Am Coll Cardiol; 2021 Mar; 77(9):1182-1193. PubMed ID: 33663735
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.